Siglimet XR 50 mg+500 mg (Tablet)

Top Selling Products

Description How to Buy return policy reviews

100% Original Product

Description:

Siglimet XR 50mg+500mg Tablet contains Sitagliptin 50 mg (as Sitagliptin Phosphate Monohydrate) and Metformin Hydrochloride 500 mg (extended-release). Manufactured by Square Pharmaceuticals PLC, it is a dual-action oral antidiabetic combination that unites a DPP-4 inhibitor (Sitagliptin) and a biguanide (Metformin) to enhance glycemic control through complementary mechanisms.

Uses:

Management of type 2 diabetes mellitus as an adjunct to diet and exercise to improve blood sugar control in adults.
Helps decrease hepatic glucose production, reduce intestinal absorption of glucose, and increase insulin release while suppressing excess glucagon secretion in a glucose-dependent manner.

Dose:

Adults: Typically taken once daily with a meal, preferably in the evening, to reduce potential gastrointestinal discomfort.
Dosage must be individualized by a physician based on current treatment regimen, effectiveness, and tolerability, without exceeding the maximum daily dose (100 mg Sitagliptin / 2000 mg Metformin).
Swallow whole; do not crush, chew, or split the extended-release tablet. Use strictly as prescribed by a healthcare professional.